These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7669080)

  • 1. Regression of transplant coronary artery disease during chronic HELP therapy: a case study.
    Park JW; Vermeltfoort M; Braun P; May E; Merz M
    Atherosclerosis; 1995 May; 115(1):1-8. PubMed ID: 7669080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis.
    Park JW; Merz M; Braun P
    J Heart Lung Transplant; 1997 Mar; 16(3):290-7. PubMed ID: 9087872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal.
    Lane DM; McConathy WJ; Laughlin LO; Comp PC; von Albertini B; Gibson SM; Bricker LA; Kozlovskis P; Dorrier C
    Am J Cardiol; 1993 Apr; 71(10):816-22. PubMed ID: 8456760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia.
    Pfefferkorn TK; Knüppel HP; Jaeger BR; Thiery J; Hamann GF
    Stroke; 1999 Sep; 30(9):1802-6. PubMed ID: 10471427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation.
    Schuff-Werner P; Gohlke H; Bartmann U; Baggio G; Corti MC; Dinsenbacher A; Eisenhauer T; Grützmacher P; Keller C; Kettner U
    Eur J Clin Invest; 1994 Nov; 24(11):724-32. PubMed ID: 7890009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P
    Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: absolute levels or extent of lowering?
    Cullen P; Assmann G
    Am J Cardiol; 1997 Nov; 80(10):1287-94. PubMed ID: 9388100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy.
    Lane DM; McConathy WJ; Laughlin LO; Comp PC; von Albertini B; Bricker LA; Kozlovskis P; Lees RS; Dorrier C
    Atherosclerosis; 1995 Apr; 114(2):203-11. PubMed ID: 7605389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D; Mellwig KP
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six years of treatment with the HELP system of a patient with familial hypercholesterolemia.
    Nascimento MM; Pasqual DD; dos Santos JE; Riella MC
    Braz J Med Biol Res; 2002 Jul; 35(7):775-82. PubMed ID: 12131916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresis.
    Wenke K; Thiery J; Arndtz N; Meiser BM; Seidel D; Reichart B
    Transplant Proc; 1992 Dec; 24(6):2674-6. PubMed ID: 1465897
    [No Abstract]   [Full Text] [Related]  

  • 18. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of long-term LDL-apheresis in patients at high risk.
    Thiery J; Seidel D
    Curr Opin Lipidol; 1998 Dec; 9(6):521-6. PubMed ID: 9868586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.
    Jaeger BR
    Ther Apher; 2001 Jun; 5(3):207-11. PubMed ID: 11467757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.